Table:
begin	end	state
1	21	cytoplasmic
22	40	transmembrane
41	55	non-cytoplasmic
56	77	transmembrane
78	106	cytoplasmic
107	130	transmembrane
131	135	non-cytoplasmic
136	159	transmembrane
160	161	cytoplasmic
162	182	transmembrane
183	186	non-cytoplasmic
187	208	transmembrane
209	214	cytoplasmic
215	234	transmembrane
235	275	non-cytoplasmic
276	297	transmembrane
298	329	cytoplasmic
330	349	transmembrane
350	364	non-cytoplasmic
365	392	transmembrane
393	412	cytoplasmic
413	430	transmembrane
431	461	non-cytoplasmic

Input:
>YP_001328063.1 NCBI__GCF_000017145.1:YP_001328063.1
MANVASTTASAGSELTARALREAVFAGLITLGLFVLFVGLKSDQNIRNELILTQRWGLLA
IFVAVAMVGRFLIVVYVQPRFAKRKAAKAAAPDVVKKDTFFTRQWPKIAVVMLLLYPPVI
VSFVGVQGSLKWVDNFGIQILIYVMLAWGLNIVVGLAGLLDLGYVAFYAVGAYSYALLSS
YFGLSFWVLLPVAGLLAALWGIVLGFPVLRLRGDYLAIVTLAFGEIIRLVLINWTEVTKG
TFGVSGIAKATLFGIKFDASKDGFAALFDLPLSSAYYKIFLFYLILALALLTAFVTIRLR
RMPIGRAWEALREDEIACRSLGINTVTTKLTAFATGAMFGGFAGSFFAVRQGFVSPESFV
FLESAVILAIVVLGGMGSLTGIAIAAVVMIGGTEILRELTFLKMIFGPAFTPELYRMLIF
GLAMVTVMVWKPRGFVGSREPTAFLRQRRAVSGSFTKEGHG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server